A Reminder App to Optimize Bladder Filling in Patients with Prostate Cancer Receiving HYPO-fractionated Radiotherapy
Condition(s) studied
Investigational drug(s) / intervention(s)
Reminder App: The purpose of the app is to remind patients irradiated for prostate cancer in an intuitive, unobtrusive and supportive way to drink 300 ml of water 45 minutes prior to each radiation session.
Study summary
The primary goal of this study is to assess the impact of an app that reminds patients treated with hypofractionated radiotherapy (HF-RT) for prostate cancer to drink water prior to each radiotherapy session on the number of bladder volumes \<200 ml during the HF-RT course and to demonstrate that this number is lower than without using an app (historical control group).
Eligibility
Primary outcome measure(s)
- Number of fractions with bladder volumes <200 ml at the end of the radiotherapy course — through study completion, an average of 4 weeks
The primary endpoint is the number of radiation fractions with bladder volumes \<200 ml at the end of the radiotherapy course. The bladder volume at each radiation fraction is calculated from the corresponding Cone-Beam Computed Tomography (CBCT).
Trial sites (4)
| Facility | City | Region | Status |
|---|---|---|---|
| Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark | Vejle | Southern Denmark | |
| Medical Practice for Radiotherapy and Radiation Oncology | Hanover | Lower Saxony | |
| Department of Radiation Oncology, University of Lübeck and University Medical Center Schleswig-Holstein | Lübeck | Schleswig-Holstein | |
| Radiation Oncology Department, Hospital Universitario Cruces/Biobizkaia Health Research Institute University of the Basque Country | Barakaldo | Basque Country |
More University Hospital Schleswig-Holstein trials in Denmark
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06784115 on ClinicalTrials.gov ↗ ← All trials in Denmark